Sasya Bio-Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 26-05-2024
- Paid Up Capital ₹ 2.23 M
as on 26-05-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 26-05-2024
- Satisfied Charges ₹ 8.98 M
as on 26-05-2024
About Sasya Bio-Remedies
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.23 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹8.98 M, as per Ministry of Corporate Affairs (MCA) records.
Durga Pittala, Jhansi Mekala, Lakshmiprasad Mekala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239AP2001PTC036554
- Company No.
036554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2001
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sasya Bio-Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lakshmiprasad Mekala  | Managing Director | 12-Apr-2001 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jhansi Mekala | Whole-Time Director | 12-Apr-2001 | Current |
| Durga Pittala | Whole-Time Director | 12-Apr-2001 | Current |
| Ramachandra Pittala | Whole-Time Director | 12-Apr-2001 | Current |
Financial Performance and Corporate Structure Insights of Sasya Bio-Remedies.
Sasya Bio-Remedies Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sasya Bio-Remedies?
In 2017, Sasya Bio-Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sujay Bio-Tech Private LimitedActive 23 years 8 monthsLakshmiprasad Mekala and Ramachandra Pittala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 08 Sep 2009 | ₹2.50 M | Open |
Union Bank Of India Creation Date: 04 Dec 2003 | ₹1.30 M | Satisfied |
Union Bank Of India Creation Date: 28 Mar 2002 | ₹4.80 M | Satisfied |
How Many Employees Work at Sasya Bio-Remedies?
Unlock and access historical data on people associated with Sasya Bio-Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sasya Bio-Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sasya Bio-Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
